These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 87092)
1. Clinical trial of a new chromone compound for systemic treatment of atopic dermatitis. Larsen PO; Larsen FS Acta Derm Venereol; 1979; 59(3):270-1. PubMed ID: 87092 [TBL] [Abstract][Full Text] [Related]
2. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415 [TBL] [Abstract][Full Text] [Related]
3. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children]. Giannetti A; Laria G; Seidenari S Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158 [No Abstract] [Full Text] [Related]
4. [Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis]. Gip L Tidsskr Nor Laegeforen; 1978 Apr; 98(10):509-10. PubMed ID: 354085 [No Abstract] [Full Text] [Related]
5. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-inflammatory treatment in atopic dermatitis]. Queille-Roussel C; Dahan C; Poncet M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J Therapie; 1991; 46(3):193-6. PubMed ID: 1792650 [TBL] [Abstract][Full Text] [Related]
6. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Kaplan RJ; Daman L; Rosenberg EW; Feigenbaum S Arch Dermatol; 1978 Jan; 114(1):60-2. PubMed ID: 339846 [TBL] [Abstract][Full Text] [Related]
7. Double-blind crossover trial comparing systemic chromosome-carboxylic acid with placebo in patients with atopic dermatitis. Kavli G; Larsen PO Allergy; 1981 Nov; 36(8):597-600. PubMed ID: 7039401 [TBL] [Abstract][Full Text] [Related]
8. [Calmuril-hydrocortisone and carbamide-hydrocortisone DAK. A comparison in the treatment of atopic dermatitis]. Andersen KE; Brandrup F; Jacobsen M Ugeskr Laeger; 1979 Dec; 141(51):3512-4. PubMed ID: 395746 [No Abstract] [Full Text] [Related]
9. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648 [TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind comparison of alclometasone dipropionate 0.05% cream in atopic dermatitis and other dermatoses. Panja SK; Gangopadhaya AK; Sharma SD Indian J Dermatol; 1988 Jan; 33(1):1-4. PubMed ID: 3074044 [No Abstract] [Full Text] [Related]
12. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis]. Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856 [TBL] [Abstract][Full Text] [Related]
13. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis. Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989 [TBL] [Abstract][Full Text] [Related]
15. Amcinonide (Cyclocort) - a new topical corticosteroid. Med Lett Drugs Ther; 1980 Jun; 22(12):51-2. PubMed ID: 6990221 [No Abstract] [Full Text] [Related]
16. Ketotifen in the treatment of atopic dermatitis. Results of a double blind study. Falk ES Riv Eur Sci Med Farmacol; 1993; 15(2):63-6. PubMed ID: 8171216 [TBL] [Abstract][Full Text] [Related]
17. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724 [TBL] [Abstract][Full Text] [Related]
18. Subpopulations of lymphocytes and lymphocyte transformation tests in atopic dermatitis: evaluation of a systemic treatment with a new chromone compound and comparison with a normal group. Birkeland SA; Larsen PO; Larsen FS J Invest Dermatol; 1981 May; 76(5):367-70. PubMed ID: 7014726 [TBL] [Abstract][Full Text] [Related]
19. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. Svejgaard El; Larsen PØ; Deleuran M; Ternowitz T; Roed-Petersen J; Nilsson J J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):445-9. PubMed ID: 15196159 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Capella GL; Grigerio E; Altomare G Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]